Summary
The uptake and subsequent metabolism by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO) of dopamine, adrenaline, isoprenaline and noradrenaline in isolated perfused lungs of rats has been examined. In lung preparations in which COMT and MAO were inhibited, the uptake of 3H-labelled dopamine, (−)-adrenaline and (−)-noradrenaline, but not (±)-isoprenaline, was reduced by cocaine (10 or 100 μmol/l) The rank order of the Km values of the amines that were substrates for uptake in the lungs were: dopamine (0.246 μmol/l) < noradrenaline (0.967 μmol/l) < adrenaline (3.32 μmol/l). These results are consistent with transport of catecholamines in rat lungs by Uptake1.
In lung preparations with COMT and MAO intact, dopamine and noradrenaline were removed from the circulation (50% and 32%, respectively) and mainly metabolized. There was very little (3.0%) removal of isoprenaline by the lungs and adrenaline was not included in this part of the study. In lung preparations in which only MAO was inhibited, the rank order of COMT activity for O-methylation of the amines was dopamine ≪ noradrenaline ≥ adrenaline (kCOMT values: 4.98 min−1, 0.357 min−1, and 0.234 min−1, respectively).
If dopamine or adrenaline are perfused through the pulmonary circulation in isolated lungs of the rat, they are taken up and then metabolized by COMT and MAO, as also occurs for noradrenaline. Isoprenaline is not a substrate for uptake in the lungs. There was less uptake of adrenaline than noradrenaline, indicating that uptake and metabolism in the lungs may not be a significant removal process for adrenaline in the circulation of rats in vivo. The more marked uptake of dopamine (than of noradrenaline) indicates that uptake and metabolism by the lungs, at least in the rat, may play an important role in the removal of dopamine from the circulation in vivo.
Similar content being viewed by others
Abbreviations
- COMT:
-
catechol-O-methyltransferase
- DOMA:
-
3,4-dihydroxymandelic acid
- DOPAC:
-
3,4-dihydroxyphenylacetic acid
- DOPEG:
-
3,4-dihydroxyphenylglycol
- DOPET:
-
3,4-dihydroxyphenyl ethanol
- MAO:
-
monoamine oxidase
- MN:
-
metanephrine
- MTA:
-
3-methoxytyramine
- NMN:
-
normetanephrine
- OMDA:
-
O-methylated deaminated metabolites
- OMI:
-
3-O-methylisoprenaline
- U-0521:
-
3,4-dihydroxy-2-methylpropiophenone
References
Alabaster VA, Bakhle YS (1973) The removal of noradrenaline in the pulmonary circulation of rat isolated lungs. Br J Pharmacol 47:325–331
Bakhle YS (1990) Pharmacokinetic and metabolic properties of lung. Br J Anaesth 65:79–93
Boileau J-C, Campeau L, Biron P (1970) Pulmonary fate of histamine, isoproterenol, physalaemin, and substance P. Can J Physiol Pharmacol 48:681–684
Boileau J-C, Campeau L, Biron P (1971) Comparative pulmonary fate of intravenous epinephrine. Rev Can Biol 30:281–286
Boileau J-C, Crexells C, Biron P (1972) Free pulmonary passage of dopamine. Rev Can Biol 31:69–72
Bönisch H (1978) Further studies on the extraneuronal uptake and metabolism of isoprenaline in the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 303:121–131
Bryan LJ, O'Donnell SR (1987) Adrenaline is a substrate for uptake and metabolism in perfused lungs of the rat. Clin Exp Pharmacol Physiol [Suppl] 11:224
Bryan LJ, O'Donnell SR (1988) Uptake of catecholamines in perfused lungs of the rat occurs by a process indistinguishable from uptake into noradrenergic neurones. Clin Exp Pharmacol Physiol [Suppl] 12:9
Bryan LJ, O'Donnell SR, Westwood NN (1989) Further evidence that the uptake process for catecholamines in pulmonary endothelial cells is the same as Uptake, in noradrenergic neurones. Clin Exp Pharmacol Physiol [Suppl] 14:27
Bryan-Lluka LJ (1990) Metabolism of dopamine in isolated perfused lungs of the rat — comparison with noradrenaline. Clin Exp Pharmacol Physiol [Suppl] 17:8
Bryan-Lluka LJ, Westwood NN, O'Donnell SR (1992) Vascular uptake of catecholamines in perfused lungs of the rat occurs by the same process as Uptake1 in noradrenergic neurones. Naunyn-Schmiedeberg's Arch Pharmacol 345:319–326
Burgen ASV, Iversen LL (1965) The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart. Br J Pharmacol 25:34–49
Catravas JD, Gillis CN (1980) Pulmonary clearance of [14C]-5-hydroxytryptamine and [3H]norepinephrine in vivo: Effects of pretreatment with imipramine or cocaine. J Pharmacol Exp Ther 213:120–127
Catravas JD, Gillis CN (1983) Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: Kinetics and sites of removal. J Pharmacol Exp Ther 224:28–33
Cubeddu LX, Hoffmann IS, Ferrari GB (1979) Metabolism and efflux of [3H]dopamine in rat neostriatum: Presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid. J Pharmacol Exp Ther 209: 165–175
Fiebig ER, Trendelenburg U (1978) The neuronal and extraneuronal uptake and metabolism of 3H-(−)-noradrenaline in the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 303:21–35
Friedgen B (1991) Evidence for blood cells contributing to the plasma clearance of catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol 343:R96
Geigy SA (1962) In: Documenta Geigy scientific tables, 6th edn. Geigy Pharmaceuticals, Sydney, Australia, pp 160–165
Gillis CN, Iwasawa Y (1972) Technique for measurement of norepinephrine and 5-hydroxytryptamine uptake by rabbit lungs. J Appl Physiol 33:404–408
Gillis CN, Roth JA (1977) The fate of biogenic monoamines in perfused rabbit lung. Br J Pharmacol 59:585–590
Gillis CN, Greene NM, Cronau LH, Hammond GL (1972) Pulmonary extraction of 5-hydroxytryptamine and norepinephrine before and after cardiopulmonary bypass in man. Circ Res 30:666–674
Ginn R, Vane JR (1968) Disappearance of catecholamines from the circulation. Nature 219:740–742
Grohmann M (1987) The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 336:139–147
Grohmann M, Trendelenburg U (1984) The substrate specificity of uptake2 in the rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 328:164–173
Hughes J, Gillis CN, Bloom FE (1969) The uptake and disposition of dl-norepinephrine in perfused rat lung. J Pharmacol Exp Ther 169:237–248
Iwasawa Y, Gillis CN, Aghajanian G (1973) Hypothermic inhibition of 5-hydroxytryptamine and norepinephrine uptake by lung: Cellular location of amines after uptake. J Pharmacol Exp Ther 186:498–507
Langeloh A, Bönisch H, Trendelenburg U (1987) The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: Multifactorial induction of outward transport. Naunyn-Schmiedeberg's Arch Pharmacol 336:602–610
Nicholas TE, Strum JM, Angelo LS, Junod AF (1974) Site and mechanism of uptake of 3H-l-norepinephrine by isolated perfused rat lungs. Circ Res 35:670–680
Russell WJ, Frewin DB, Jonsson JR (1982) Pulmonary extraction of catecholmines in critically ill patients. Anaesth Intens Care 10:319–323
Schömig E, Körber M, Bönisch H (1988) Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier. Naunyn-Schmiedeberg's Arch Pharmacol 337:626–632
Snedecor GW, Cochran WG (1989) Statistical methods, 8th edn. Iowa State University Press, Ames, USA, pp 149–175
Sole MJ, Drobac M, Schwartz L, Hussain MN, Vaughan-Neil EF (1979) The extraction of circulation catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation 60:160–163
Sumikawa K, Hirano H (1986) Quantitative analysis of the contribution of pulmonary and hind limb circulation to the clearance of exogenous catecholamines. J Pharmacol Exp Ther 236:759–763
Trendelenburg U (1984) The influence of inhibition of catechol-O-methyl transferase or of monoamine oxidase on the extraneuronal metabolism of 3H-(−)-noradrenaline in the rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 327:285–292
Tendelenburg U, Stefano FJE, Grohmann M (1983) The isotope effect of tritium in 3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 323:128–140
Author information
Authors and Affiliations
Additional information
Some of the results of this study were presented to the Australasian Society of Clinical and Experimental Pharmacologists (Bryan and O'Donnell 1987, 1988; Bryan et al. 1989; Bryan-Lluka 1990)
Send offprint requests to L.J. Bryan-Lluka at the above address
Rights and permissions
About this article
Cite this article
Bryan-Lluka, L.J., O'Donnell, S.R. Dopamine and adrenaline, but not isoprenaline, are substrates for uptake and metabolism in isolated perfused lungs of rats. Naunyn-Schmiedeberg's Arch Pharmacol 346, 20–26 (1992). https://doi.org/10.1007/BF00167565
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167565